XLP Shorts Rebuild as Options Hedging Intensifies

The short cover that defined XLP through most of October has gone into reverse, and options markets are amplifying the cautious signal.

Short interest has climbed back sharply after its mid-month trough. It rose 16% over the past seven days to reach nearly 23.1 million shares, or just under 12% of the free float. That weekly jump is roughly 1.9 standard deviations above the ETF's typical week-on-week move, making it one of the more abrupt rebuilds in the past year. The previous ORTEX note from October 21 described a sustained short-cover rally, with short interest having fallen to around 9.9% of float. That retreat has now partially reversed, and the direction of travel has flipped. The borrow market reflects the shift: availability has tightened considerably, dropping more than 54% on the week to 103%, from above 227% just days ago. That still leaves roughly one share available for every one already borrowed, so conditions are not yet squeezed, but the directional move is meaningful. Cost to borrow remains low at 0.64%, up only modestly on the week, so the cost of holding a short position is not yet a constraint.

Options positioning reinforces the defensive lean. The put/call ratio has climbed further to 5.61, now more than 2.4 standard deviations above its 20-day average of 3.59. That elevated reading points to persistent demand for downside protection, consistent with the trend flagged in the October 21 note when the PCR was already running above its norm at 3.89. The gap between where the PCR sits now and where it averaged through September and early October is notable: from mid-September through to around October 14, readings rarely moved above 3.3. The acceleration since then suggests hedging demand has continued to build even as XLP itself recovered.

The price context matters here. XLP closed at $87.15 on October 27, down 0.9% on the day and off 0.7% on the week, though still up 6.2% over the past month. The monthly gain is the backdrop against which shorts are rebuilding: the fund's defensive character attracted buyers as consumer staples outperformed through much of October, and short sellers who covered into that move are now, on the evidence of the past week, rebuilding positions. The ORTEX short score has edged up to 65.2, from 58.2 a week ago, a moderate but consistent drift higher that aligns with the short interest data.

Institutional positioning, as of the most recent quarterly filings in June, showed most large holders trimming. Morgan Stanley, Goldman Sachs, JPMorgan and Raymond James all cut positions. Citigroup and BNP Paribas bucked the trend, each adding meaningfully. That picture is now several months stale, but it is consistent with the ETF's role as a tactical vehicle: holders move in and out based on macro positioning rather than fundamental conviction on any single name.

The key question heading into next week is whether the short rebuild continues at this pace or stabilises. Short interest is still comfortably below the late-September peak of around 24.6 million shares, but the pace of the past seven days has closed about a third of that gap in one move. The put/call ratio is worth watching alongside it: if the PCR retreats toward its 20-day average even as short interest holds, that would suggest hedgers are satisfied rather than still adding. If both keep climbing together, the positioning picture for this defensive fund grows more charged.